Compare Sana Biotechnology Inc (SANA) vs T Rowe Price Group Inc (TROW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs T Rowe Price Group Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while T Rowe Price Group Inc trades at $115.59 (market cap $25.14B). The key difference: T Rowe Price Group Inc is far larger — about 28.8× Sana Biotechnology Inc's market cap, and T Rowe Price Group Inc pays a 4.43% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TROW | |
|---|---|---|
Market Cap | $873.84M | $25.14B |
Sector | Health | Financials |
52-Week High | $5.92 | $120.16 |
52-Week Low | $2.68 | $86.19 |
Enterprise Value | $848.03M | $21.85B |
Dividend Yield | — | 4.43% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About T Rowe Price Group Inc
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →
